ABSTRACT
Annular epidermolytic ichthyosis is a rare subtype of epidermolytic ichthyosis that is characterized by erythematous, polycyclic, and migratory scaly plaques accompanied by palmoplantar keratoderma. This report presents the case of an 8-year-old girl who developed migratory, erythematous, scaly plaques associated with palmoplantar keratoderma. The initial hypothesis was erythrokeratodermia variabilis et progressiva; however, the finding of epidermolytic hyperkeratosis in histopathological examination led to the diagnosis of annular epidermolytic ichthyosis.
Subject(s)
Hyperkeratosis, Epidermolytic , Child , Exanthema , Female , Humans , Keratoderma, Palmoplantar , SkinABSTRACT
O retalho trilobado pode ser usado para a reconstrução de defeitos de tamanho médio da porção nasal inferior. O terceiro lóbulo determina o aumento do arco rotatório, reduzindo a tensão do retalho e melhorando a estética final. Relatamos o caso da uma paciente submetida ao procedimento com bom resultado estético e funcional.
The trilobate flap can be used for the reconstruction of mid-size defects of the lower nasal portion. The third lobe determines the rotational arch's increase, reducing the flap tension and improving the final aesthetics. We report the case of a patient submitted to the procedure with good aesthetic and functional results
ABSTRACT
This is a case report about Porphyria cutanea tarda (PCT) and its relationship with the infection caused by the human immunodeficiency virus (HIV). Cutaneous porphyria is an illness caused by enzymatic modification that results in partial deficiency of uroporphyrinogen decarboxylase (Urod), which may be hereditary or acquired. Several studies suggest that HIV infection associated with cofactors might trigger the development of porphyria cutanea tarda. In this case report, we present a patient infected with HIV, who after the introduction of antiretroviral therapy (ART) enjoyed clinical improvement of porphyria cutanea tarda symptoms.
Subject(s)
HIV Infections/complications , Porphyria Cutanea Tarda/pathology , Porphyria Cutanea Tarda/virology , Antiretroviral Therapy, Highly Active , HIV Infections/drug therapy , Humans , Male , Middle Aged , Porphyria Cutanea Tarda/drug therapy , Risk Factors , Skin/pathology , Uroporphyrinogen Decarboxylase/urineABSTRACT
Abstract: This is a case report about Porphyria cutanea tarda (PCT) and its relationship with the infection caused by the human immunodeficiency virus (HIV). Cutaneous porphyria is an illness caused by enzymatic modification that results in partial deficiency of uroporphyrinogen decarboxylase (Urod), which may be hereditary or acquired. Several studies suggest that HIV infection associated with cofactors might trigger the development of porphyria cutanea tarda. In this case report, we present a patient infected with HIV, who after the introduction of antiretroviral therapy (ART) enjoyed clinical improvement of porphyria cutanea tarda symptoms.
Subject(s)
Humans , Male , Middle Aged , HIV Infections/complications , Porphyria Cutanea Tarda/pathology , Porphyria Cutanea Tarda/virology , Skin/pathology , Uroporphyrinogen Decarboxylase/urine , HIV Infections/drug therapy , Risk Factors , Porphyria Cutanea Tarda/drug therapy , Antiretroviral Therapy, Highly ActiveABSTRACT
We aimed to evaluate the effects of a 24-h ultramarathon, an aerobic test of high physical load, on lipid profile and apolipoproteins B (ApoB) and A1 (ApoA1) levels, minimally modified low-density lipoprotein (LDL), and oxidised LDL. Prospective evaluation of 16 male athletes who participated in an ultramarathon run, where the objective was to run the greatest distance possible in 24 h. Fourteen participants completed the run. The mean distance achieved was 133.1 km (maximum of 169.6 km). There was a trend in reduction of triglycerides and total cholesterol (P = 0.06 and 0.05, respectively), without significant modifications in high-density lipoprotein, LDL and ApoA1 levels (P = 0.16; 0.55 and 0.67). There was a marked reduction in ApoB levels (P < 0.001), correlated directly to the distance covered (Pearson R = 0.68). Accordingly, an increase in the LDL/ApoB ratio was observed. The stress of this physical activity was not associated to an increase in minimally modified LDL or oxidised LDL. Lipid profile levels were not acutely altered by prolonged physical activity. Similarly, there was no evidence of greater oxidation of LDL over a 24-h period of physical activity. The reduction in ApoB was directly proportional to the distance covered, suggesting an acute positive change in phenotype of LDL molecules.